Static Chart Biomind Labs Inc. OTC Markets

Equities

Delayed OTC Markets Other stock markets 03:14:29 2024-04-04 pm EDT			5-day change	1st Jan Change
0.11 ^USD	-.--%		-.--%	-89.00%

2023	Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications	CI
2023	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Duration

Period